CALL US: 210-949-0122
Studies for Seniors »

by: Rick Greenfield

Many people can remember when Pfizer introduced a game-changing drug, Viagra, to help men across the globe with sexual performance problems related to erectile dysfunction (ED). The introduction of Viagra and now several other copy-cat drugs has had a huge effect on millions of men who suffer from ED, but what about the ladies? There are millions of women, up to 43%, that also suffer from sexual dysfunction.

While the issue of sexual dysfunction presents differently between the sexes, the mental and emotional distress that result from sexual dysfunction are quite similar. At present, there are no FDA approved medications for women who suffer from sexual dysfunction, also known as Hypoactive Sexual Desire Disorder (HSDD).

So what is HSSD and how does a woman know if she truly has it?

HSDD is commonly characterized by a lack of desire for sexual activity. There are varying reasons why a woman may or may not have interest in sexual activity. Some women have never had sexual desire while others once had it, but have since lost interest. This distinction in HSDD onset is clinically categorized as either “Lifelong” or “Acquired.” Additionally, a woman’s desire to engage in sexual activity may be related to specific environmental factors such as having a lack of interest in a sexual partner or other environmental circumstances. For other women, a lack of sexual interest may be general and present in any environmental circumstance. Clinicians distinguish environmental factors surrounding HSDD as either “Situational” or “Generalized.”

Since lifelong HSDD may be a much larger problem, and since situational HSDD may have nothing to do with physiological components, the goal of clinical researchers is to find a cure for Acquired/Generalized HSDD. Some scientists theorize that, in acquired/generalized HSDD, decreases in certain hormones in a woman may be a contributing factor to low sex drive; and therefore, many new drugs being developed target these hormonal deficits.

Clinical Trials of Texas, Inc. (CTT) is conducting a new study in the San Antonio area that is testing an investigational medication for the treatment of acquired/generalized HSDD. Women who think that they may have acquired/generalized HSDD can find out more about how to volunteer for this study by calling CTT at (210) 949-0122 or visit SAresearch.com.

CTT is dedicated to “Promoting Health through Research” and has been conducting studies in San Antonio for over 13 years.